Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 6/20 | 1.00 |
| ▸ | NR4A1 | P22736 | 1/20 | 1.00 |
| ▸ | NR4A3 | Q92570 | 1/20 | 1.00 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.90 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.84 |
| ▸ | MAOB | P27338 | 1/20 | 0.74 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.74 |
| ▸ | RXRA | P19793 | 5/20 | 0.72 |
| ▸ | RXRB | P28702 | 5/20 | 0.72 |
| ▸ | NPC1 | O15118 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | RAB9A | P51151 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | RXRG | P48443 | 1/20 | 0.69 |
| ▸ | PKM | P14618 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4059143 | 1.00 | NR4A2 (1.00) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| SCHEMBL6830467 | 1.00 | NR4A2 (1.00) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| SCHEMBL11603952 | 0.98 | NR4A2 (0.96) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| SCHEMBL11603274 | 0.98 | NR4A2 (0.96) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| Hydrochloric Acid SCHEMBL8544438 | 0.98 | NR4A2 (0.96) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| SCHEMBL11273693 | 0.98 | NR4A2 (0.96) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| SCHEMBL4949143 | 0.95 | NR4A2 (0.90) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| SCHEMBL1221359 | 0.95 | NR4A2 (0.90) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| Benzil SCHEMBL7771752 | 0.93 | NR4A2 (0.87) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B | |
| Hydrochloric Acid SCHEMBL8378883 | 0.93 | NR4A2 (0.87) | NR4A2NR4A1NR4A3SRD5A2PLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115302920-A | Antibacterial, mildewproof and antiviral leather and preparation method thereof | 天守(福建)超纤科技股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-115212314-A | Albumin-bound antitumor drug and nano-composite thereof, and preparation method and application thereof | 沈阳药科大学 | 2022-10-21 | — | — | CN | claimed |
| EP-2993055-B1 | Web-shaped heat-sensitive recording material with a protective layer | MITSUBISHI HITEC PAPER EUROPE GMBH (DE) | 2019-04-03 | — | — | EP | claimed |
| EP-3352991-B1 | HEAT SENSITIVE RECORDING MATERIAL | MITSUBISHI HITEC PAPER EUROPE GMBH (DE) | 2019-01-30 | — | — | EP | claimed |
| EP-2279732-A2 | Compounds and compositions for delivering active agents | Emisphere Technologies, Inc. (US) | 2011-02-02 | — | — | EP | claimed |
| CN-101914118-A | Trehalose derivant and preparation method and application thereof | UNIV SHANDONG | 2010-12-15 | — | — | CN | claimed |
| JP-2007537301-A | — | — | 2007-12-20 | — | — | JP | claimed |
| CN-1964939-A | Compounds and compositions for delivering active agents | EMISPHERE TECH INC (US) | 2007-05-16 | — | — | CN | claimed |
| EP-1756039-A4 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECH INC (US) | 2007-05-02 | — | — | EP | claimed |
| EP-1756039-A2 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | Emisphere Technologies, Inc. (US) | 2007-02-28 | — | — | EP | claimed |
| US-20030149110-A1 | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases | HU LAIN-YEN (US) | 2003-08-07 | — | — | US | claimed |
| WO-2003045902-A1 | BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | WARNER-LAMBERT COMPANY LLC (US) | 2003-06-05 | — | — | WO | claimed |
| EP-1314723-A1 | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases | WARNER-LAMBERT COMPANY (US) | 2003-05-28 | — | — | EP | claimed |
| CN-1132508-A | Piperazine derivatives | REORDATI IND CHIMICA E FARMACE (CH) | 1996-10-02 | — | — | CN | claimed |
| EP-0301587-B1 | LIQUID CRYSTAL COMPOUNDS AND INTERMEDIATES THEREOF | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1992-07-15 | — | — | EP | claimed |
| EP-0301587-A1 | Liquid crystal compounds and intermediates thereof | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1989-02-01 | — | — | EP | claimed |
| US-4719198-A | CONTAINING P-BENZYLOXYBENZOIC ACID BENZYL ESTER; OIL-STABLE IMAGES | JUJO PAPER CO., LTD. (JP) | 1988-01-12 | — | — | US | claimed |
| EP-0066813-B1 | HEAT-SENSITIVE RECORDING SHEET | JUJO PAPER CO., LTD. (JP) | 1985-08-21 | — | — | EP | claimed |
| EP-0059975-B1 | THERMORESPONSIVE RECORDING SHEET | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1985-06-26 | — | — | EP | claimed |
| US-4098816-A | HYPOGLYCEMIC AGENTS AND ANTILIPEMIC AGENTS | BEECHAM GROUP LIMITED (GB) | 1978-07-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149110-A1 | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases | BCAT1, BCAT2, ABAT | NR4A2 4337/4885NR4A1 4778/4885NR4A3 4290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.